RARE Competitors & Alternatives
Compare Ultragenyx with similar stocks in the same industry
Biotechnology
RARE
Main Stock$15.65
Tradestie Score
40
Market Cap
$2.89B
Revenue Growth
0.3%
Analyst Upside
+67.7%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MNKD
Mannkind Corporation
|
$3.19
|
$1.65B | - | 61 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.31
|
$1.63B | - | 55 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.88
|
$1.57B | - | 40 | Compare |
|
VCEL
Vericel Corporation
|
$42.53
|
$1.56B | 91.4 | 53 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$76.78
|
$1.55B | - | 52 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$36.13
|
$1.55B | 11.6 | 59 | Compare |
|
PHVS
Pharvaris N.V. Ordinary Shares
|
$31.41
|
$1.55B | - | 55 | Compare |
|
NVAX
Novavax Inc
|
$9.70
|
$1.54B | - | 44 | Compare |
|
AUPH
Aurinia Pharmaceuticals Inc
|
$16.86
|
$1.50B | 7.6 | 49 | Compare |
|
GPCR
Structure Therapeutics Inc. American Depositary Shares
|
$21.19
|
$1.50B | - | 50 | Compare |
More RARE Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry